BMGL (Basel Medical Group) Current Accrued Expense: $1.16 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BMGL Basel Medical Group Ltd BMGL
17 GF Score
Price $4.78
! 3 Warning Signs
View Full Analysis

What is Basel Medical Group Current Accrued Expense?

Basel Medical Group BMGL 17 Current Accrued Expense is $1.16 Mil as of Dec. 2025. GuruFocus rates BMGL with a GF Score™ of 17/100. The stock has 3 warning signs investors should review.

Basel Medical Group's Current Accrued Expense for the quarter that ended in Dec. 2025 was $1.16 Mil.

Basel Medical Group's quarterly Current Accrued Expense increased from Dec. 2024 ($0.53 Mil) to Jun. 2025 ($1.12 Mil) and increased from Jun. 2025 ($1.12 Mil) to Dec. 2025 ($1.16 Mil).

Basel Medical Group's annual Current Accrued Expense increased from Jun. 2023 ($0.15 Mil) to Jun. 2024 ($0.80 Mil) and increased from Jun. 2024 ($0.80 Mil) to Jun. 2025 ($1.12 Mil).

Basel Medical Group Current Accrued Expense Related Terms

Basel Medical Group Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Basel Medical Group's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Basel Medical Group Current Accrued Expense Chart

Basel Medical Group Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Current Accrued Expense
0.53 0.15 0.80 1.12

Basel Medical Group Semi-Annual Data
Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Current Accrued Expense Get a 7-Day Free Trial 0.32 0.80 0.53 1.12 1.16
BMGL
17GF Score
Basel Medical Group Ltd BMGL
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Basel Medical Group Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $1.16 Mil mean?
Basel Medical Group (BMGL) has a Current Accrued Expense of $1.16 Mil as of Dec. 2025. Current Accrued Expense records the total amount of accrued expenses. View historical data on Basel Medical Group and its competitors.
Is Basel Medical Group's Current Accrued Expense too high?
Basel Medical Group's current Current Accrued Expense is $1.16 Mil. Overall, Basel Medical Group has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Basel Medical Group's Current Accrued Expense compare to HLYK and AMS?
Basel Medical Group's Current Accrued Expense of $1.16 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Healthcare Providers & Services company?
A good Current Accrued Expense depends on the Healthcare Providers & Services industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Basel Medical Group and its competitors. Basel Medical Group's current Current Accrued Expense is $1.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Basel Medical Group stock overvalued right now?
Basel Medical Group (BMGL) has a current Current Accrued Expense of $1.16 Mil. The current Current Accrued Expense is $1.16 Mil. Basel Medical Group's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Basel Medical Group (BMGL), the current Current Accrued Expense is $1.16 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Basel Medical Group Business Description

Address 6 Napier Road, Unit No. 02-10/11, Gleneagles Medical Centre, Singapore, SGP, 258499
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. The services provided by clinics include, but are not limited to, consultation, medical diagnosis and medical or surgical treatments for orthopedic, trauma, sports medicine, general practice, health screening, mental health, women's health and neurosurgical conditions and clinics are equipped with the facilities needed to perform a variety of procedures on site and minor surgical services. Key revenue is generated from Singapore.
17GF Score

Get the complete analysis for BMGL

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.78
Price